Novel Cancer Vaccine May Improve Survival in Synovial Sarcoma
Investigators are hopeful that CMB305, a vaccine that boosts the immune response to tumor cells expressing the antigen NY-ESO-1, can improve survival outcomes for patients with synovial sarcoma.
Source: OncLive
Tesla (Nasdaq: TSLA) Announces Date for First Quarter 2021 Financial Results and Webcast




